These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1123 related items for PubMed ID: 9062781

  • 21. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D.
    Schweiz Med Wochenschr; 1997 Jun 28; 127(26):1124-33. PubMed ID: 9312835
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 28; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

  • 23. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM, Saunders EF, Petric M, Gold R.
    Bone Marrow Transplant; 1996 Apr 28; 17(4):633-6. PubMed ID: 8722367
    [Abstract] [Full Text] [Related]

  • 24. Seroprevalence and Determinants Associated with Mumps Antibodies after 20 Years of MMR Vaccination in Urban Area of Shanghai, China.
    Pang H, Zhou Y, Zhao W, Jiang Q.
    Int J Environ Res Public Health; 2018 Sep 23; 15(10):. PubMed ID: 30249033
    [Abstract] [Full Text] [Related]

  • 25. Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.
    Levine H, Zarka S, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, Balicer RD.
    Hum Vaccin Immunother; 2015 Sep 23; 11(6):1400-5. PubMed ID: 25891446
    [Abstract] [Full Text] [Related]

  • 26. Measles, Mumps, and Rubella Serostatus and Response to MMR Vaccination Among HIV-Infected Adults.
    Singh HK, Chiu YL, Wilkin T.
    AIDS Patient Care STDS; 2015 Sep 23; 29(9):461-4. PubMed ID: 26153909
    [No Abstract] [Full Text] [Related]

  • 27. Response to measles-mumps-rubella vaccine in children on dialysis.
    Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte HJ.
    Pediatr Nephrol; 1992 Mar 23; 6(2):187-9. PubMed ID: 1571219
    [Abstract] [Full Text] [Related]

  • 28. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan 23; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 29. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.
    Poethko-Müller C, Mankertz A.
    PLoS One; 2012 Jan 23; 7(8):e42867. PubMed ID: 22880124
    [Abstract] [Full Text] [Related]

  • 30. Assessing seropositivity of MMR antibodies in individuals aged 2-22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran's National Measles Laboratory.
    Ghafoori F, Mokhtari-Azad T, Foroushani AR, Farahmand M, Shadab A, Salimi V.
    BMC Infect Dis; 2024 Jul 12; 24(1):696. PubMed ID: 38997625
    [Abstract] [Full Text] [Related]

  • 31. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis.
    Flynn JT, Frisch K, Kershaw DB, Sedman AB, Bunchman TE.
    Adv Perit Dial; 1999 Jul 12; 15():269-72. PubMed ID: 10682116
    [Abstract] [Full Text] [Related]

  • 32. Measles, mumps and rubella immunisation in children at risk of infection with human immunodeficiency virus.
    Molyneaux PJ, Mok JY, Burns SM, Yap PL.
    J Infect; 1993 Nov 12; 27(3):251-3. PubMed ID: 8308316
    [Abstract] [Full Text] [Related]

  • 33. Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine-Preventable Diseases During International Travel.
    Rosario-Rosario G, Gareca M, Kincaid H, Knouse MC.
    J Travel Med; 2015 Nov 12; 22(6):396-402. PubMed ID: 26412393
    [Abstract] [Full Text] [Related]

  • 34. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, Hurni W, Nalin DR.
    Pediatr Infect Dis J; 1996 Aug 12; 15(8):687-92. PubMed ID: 8858673
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.
    Plans P, de Ory F, Campins M, Álvarez E, Payà T, Guisasola E, Compte C, Vellbé K, Sánchez C, Lozano MJ, Aran I, Bonmatí A, Carreras R, Jané M, Cabero L.
    Eur J Clin Microbiol Infect Dis; 2015 Jun 12; 34(6):1161-71. PubMed ID: 25666082
    [Abstract] [Full Text] [Related]

  • 36. Measles, mumps, and rubella: monitoring in Switzerland through a sentinel network, 1986-94. Sentinella Arbeitsgemeinschaft.
    Matter HC, Cloetta J, Zimmermann H.
    J Epidemiol Community Health; 1995 Aug 12; 49 Suppl 1(Suppl 1):4-8. PubMed ID: 7561669
    [Abstract] [Full Text] [Related]

  • 37. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH, Lee CY, Chih TW, Lee PI, Chang LY, Lin YJ, Hsu CM, Huang LM.
    J Med Virol; 1997 Jan 12; 51(1):32-5. PubMed ID: 8986946
    [Abstract] [Full Text] [Related]

  • 38. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
    Sáenz González MC, Núñez Mateos JC, Rodrigo Sánchez N, Martín Sánchez AM.
    An Esp Pediatr; 1992 Apr 12; 36(4):293-7. PubMed ID: 1605414
    [Abstract] [Full Text] [Related]

  • 39. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
    Gil Miguel A, Astasio Arbiza P, Ortega Molina P, Domínguez Rojas V, González López A.
    An Esp Pediatr; 1999 May 12; 50(5):459-62. PubMed ID: 10394183
    [Abstract] [Full Text] [Related]

  • 40. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children.
    Usonis V, Bakasenas V, Kaufhold A, Chitour K, Clemens R.
    Pediatr Infect Dis J; 1999 Jan 12; 18(1):42-8. PubMed ID: 9951979
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.